Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Lymphoma

  Free Subscription


08.05.2017

1 Am J Pathol
3 Blood
1 Bone Marrow Transplant
4 Br J Haematol
2 Cancer
2 Hum Pathol
1 Int J Cancer
1 J Am Acad Dermatol
1 J Clin Oncol
1 Lancet Oncol
1 Leukemia
1 Oncogene


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Pathol

  1. POULIOU E, Xochelli A, Kanellis G, Stalika E, et al
    Numerous Ontogenetic Roads to Mantle Cell Lymphoma: Immunogenetic and Immunohistochemical Evidence.
    Am J Pathol. 2017 Apr 27. pii: S0002-9440(17)30012.
    PubMed     Text format     Abstract available


    Blood

  2. HAVERKOS BM, Abbott D, Hamadani M, Armand P, et al
    PD-1 blockade for relapsed lymphoma post allogeneic hematopoietic cell transplant: high response rate but frequent GVHD.
    Blood. 2017 May 3. pii: blood-2017-01-761346. doi: 10.1182/blood-2017-01-761346.
    PubMed     Text format     Abstract available

  3. KURUVILLA J, Savona M, Baz R, Mau-Sorensen M, et al
    Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin's lymphoma.
    Blood. 2017 May 3. pii: blood-2016-11-750174. doi: 10.1182/blood-2016-11-750174.
    PubMed     Text format     Abstract available

  4. JACCARD A, Hermine O
    A major turning point in NK/T-cell lymphoma?
    Blood. 2017;129:2342-2343.
    PubMed     Text format    


    Bone Marrow Transplant

  5. CASTAGNA L, Bramanti S, Devillier R, Sarina B, et al
    Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma.
    Bone Marrow Transplant. 2017;52:797.
    PubMed     Text format    


    Br J Haematol

  6. WILLIAMS ME, Hong F, Gascoyne RD, Wagner LI, et al
    Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402.
    Br J Haematol. 2016;173:867-75.
    PubMed     Text format     Abstract available

  7. BARTA SK, Joshi J, Mounier N, Xue X, et al
    Central nervous system involvement in AIDS-related lymphomas.
    Br J Haematol. 2016 Apr 7. doi: 10.1111/bjh.13998.
    PubMed     Text format     Abstract available

  8. EPPERLA N, Pham AQ, Burnette BL, Wiseman GA, et al
    Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma.
    Br J Haematol. 2017 May 3. doi: 10.1111/bjh.14688.
    PubMed     Text format     Abstract available

  9. BOYLE T, Connors JM, Gascoyne RD, Berry BR, et al
    Physical activity, obesity and survival in diffuse large B-cell and follicular lymphoma cases.
    Br J Haematol. 2017 May 3. doi: 10.1111/bjh.14702.
    PubMed     Text format     Abstract available


    Cancer

  10. KOFF JL, Flowers CR
    Prognostic modeling in diffuse large B-cell lymphoma in the era of immunochemotherapy: Where do we go from here?
    Cancer. 2017 May 2. doi: 10.1002/cncr.30740.
    PubMed     Text format    

  11. HOWLADER N, Mariotto AB, Besson C, Suneja G, et al
    Cancer-specific mortality, cure fraction, and noncancer causes of death among diffuse large B-cell lymphoma patients in the immunochemotherapy era.
    Cancer. 2017 May 2. doi: 10.1002/cncr.30739.
    PubMed     Text format     Abstract available


    Hum Pathol

  12. AGOSTINELLI C, Sabattini E, Pileri SA, Fabbri M, et al
    SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients, methodological issue on reproducibility and validity-reply.
    Hum Pathol. 2017 Apr 28. pii: S0046-8177(17)30137.
    PubMed     Text format    

  13. SABOUR S
    SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients, methodological issue on reproducibility and validity.
    Hum Pathol. 2017 Apr 27. pii: S0046-8177(17)30131.
    PubMed     Text format    


    Int J Cancer

  14. HALABI MA, Jaccard A, Moulinas R, Bahri R, et al
    Clonal deleted latent membrane protein 1 variants of Epstein-Barr virus are predominant in European extranodal NK/T lymphomas and disappear during successful treatment.
    Int J Cancer. 2016;139:793-802.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  15. LEMCHAK DM, Akilov OE
    Interleukin-12 immunohistochemistry as a diagnostic tool for patch-stage mycosis fungoides.
    J Am Acad Dermatol. 2016;75:1053-1054.
    PubMed     Text format    


    J Clin Oncol

  16. LAURENT C, Baron M, Amara N, Haioun C, et al
    Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network.
    J Clin Oncol. 2017 May 1:JCO2016712083. doi: 10.1200/JCO.2016.71.2083.
    PubMed     Text format     Abstract available


    Lancet Oncol

  17. VENKATESAN P
    Treatment options for early-stage Hodgkin's lymphoma.
    Lancet Oncol. 2017 Apr 27. pii: S1470-2045(17)30315.
    PubMed     Text format    


    Leukemia

  18. VAN DER MEULEN M, Dinmohamed AG, Visser O, Doorduijn JK, et al
    Improved survival in primary central nervous system lymphoma up to age 70 only: A population-based study on incidence, primary treatment and survival in the Netherlands, 1989-2015.
    Leukemia. 2017 Apr 28. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available


    Oncogene

  19. DAI L, Lin Z, Qiao J, Chen Y, et al
    Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma.
    Oncogene. 2017 May 1. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: